This study is designed to evaluate the feasibility, safety and preliminary efficacy of the DaRT for the treatment of Recurrent Lung Cancer.​

​

​

Participation in a clinical trial is one possible option for people who have cancer. It is recommended that patients consult with their doctor about potential participation in a clinical trial.